If you could not join the first panel of the Gene Drive Webinar Series, you can still watch the discussion here!

In this introductory session, Prof. Paul Thomas (University of Adelaide and SAHMRI) and Dr. Prasad Paradkar (CSIRO) addressed some of the most common questions related to gene drive, also providing a technical overview of how the technology works, its potential applications and research status. Ms. Krystal Birungi Mwesiga (Target Malaria, UVRI) moderated the discussion and ensuing Q&A.

The Society for Conservation Biology will host one more session of the Emerging Issues in Conservation Seminar on June 9. The online event will feature speakers whose research has been published in Conservation Biology, Conservation Letters and Conservation Science and Practice.

During the event, Claire Hirashiki (University of California), Michele Weber and Ben Novak (Revive & Restore) will discuss two papers - Concern over hybridization risks should not preclude conservation interventions and U.S. conservation translocations: Over a century of intended consequences.

A recent article by the International Institute for Sustainable Development (IISD) explores how the experience gained within the framework of the Cartagena Protocol on Biosafety to the Convention on Biological Diversity (CBD) can help regulate synthetic biology, gene drives and other emerging technologies.

The World Health Organisation (WHO) recently released the updated version of the Guidance Framework for Testing of Genetically Modified Mosquitoes, including those incorporating gene drive. The publication intends to inform future research and development on genetically modified mosquitoes, describing best practices to ensure that the study and evaluation of genetically modified mosquitoes as public health tools is safe, ethical and rigorous.

According to Dr Soumya Swaminathan, WHO Chief Scientist, genetically modified mosquitoes have raised hopes for the availability of new, potent and cost-effective tools to fight vector-borne diseases. He also emphasised the need to conduct careful and rigorous testing, including under natural conditions, to ensure that genetically modified mosquitoes are effective and safe.